A recent Biotech IPO that could be putting in the bottom of its IPO base. Breaking its downtrend (red line) and volatility contracting and forming a tight box setup. On focus list for next week.
Immunocore Hldgs Plc Ads (IMCR)- DEVELOPS AND MARKETS IMMUNOTHERAPIES WITH T-CELL RECEPTORS TO TREAT CANCER, INFECTIOUS AND AUTOIMMUNE.
Immunocore Hldgs Plc Ads (IMCR)- DEVELOPS AND MARKETS IMMUNOTHERAPIES WITH T-CELL RECEPTORS TO TREAT CANCER, INFECTIOUS AND AUTOIMMUNE.
✔ Momentum & Breakout Trader Since 2006 | Influenced by Mark Minervini VCP Trading Style & William O'Neil CANSLIM 📈
✔ Follow me on Twitter @taplot - twitter.com/TaPlot
✔ YouTube channel youtube.com/@taplot
✔ Follow me on Twitter @taplot - twitter.com/TaPlot
✔ YouTube channel youtube.com/@taplot
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
✔ Momentum & Breakout Trader Since 2006 | Influenced by Mark Minervini VCP Trading Style & William O'Neil CANSLIM 📈
✔ Follow me on Twitter @taplot - twitter.com/TaPlot
✔ YouTube channel youtube.com/@taplot
✔ Follow me on Twitter @taplot - twitter.com/TaPlot
✔ YouTube channel youtube.com/@taplot
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.